Intravenous iron supplementation in distance runners with low or suboptimal ferritin

Medicine and Science in Sports and Exercise

Volumn 46, Issue 2, 2014, Pages 376-385

  Garvican, Laura A ^a,b   Saunders, Philo U ^b   Cardoso, Tanusha ^b   Macdougall, Iain C ^c   Lobigs, Louisa M ^b   Fazakerley, Ruth ^b   Fallon, Kieran E ^b   Anderson, Bev ^b   Anson, Judith M ^a   Thompson, Kevin G ^a   Gore, Christopher J ^a,b  

^a UNIVERSITY OF CANBERRA   (Australia)

^b Australian Institute of Sport   (Australia)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

ERYTHROPOIESIS; FERRIC CARBOXYMALTOSE; HEMOGLOBIN MASS; IRON DEFICIENCY; VO2max

Indexed keywords

ANTIANEMIC AGENT; FERRIC CARBOXYMALTOSE; FERRIC ION; FERRITIN; HEMOGLOBIN; MALTOSE;

ADOLESCENT; ADULT; ANAEROBIC THRESHOLD; ANALOGS AND DERIVATIVES; BLOOD; DEFICIENCY; DIETARY SUPPLEMENT; DRUG EFFECTS; ENDURANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; OXYGEN CONSUMPTION; PHYSIOLOGY; RUNNING; TIME FACTOR; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANAEROBIC THRESHOLD; DIETARY SUPPLEMENTS; FEMALE; FERRIC COMPOUNDS; FERRITINS; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; MALTOSE; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; RUNNING; TIME FACTORS; YOUNG ADULT;

EID: 84895074329     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e3182a53594     Document Type: Article

References (50)

1. Ackrell BA, Kearney EB, Mims WB, Peisach J, Beinert H. Ironsulfur cluster 3 of beef heart succinate-ubiquinone oxidoreductase is a 3-iron cluster. J Biol Chem. 1984;259:4015-8.
2. Alexander AC, Garvican LA, Burge CM, Clark SA, Plowman JS, Gore CJ. Standardising analysis of carbon monoxide rebreathing for application in anti-doping. J Sci Med Sport. 2010;14:100-5.
3. Bailie GR. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. Arzneimittelforschung. 2010;60:386-98.
4. Burke LM. Practical Sports Nutrition. Champaign (IL): Human Kinetics; 2007. 109-39.
5. Dunn LL, Suryo Rahmanto Y, Richardson DR. Iron uptake and metabolism in the new millennium. Trends Cell Biol. 2007; 17:93-100.
6. Eichner ER. Sports anemia, iron supplements, and blood doping. Med Sci Sports Exerc. 1992;24(9 Suppl):S315-8.
7. Eichner ER. Pearls and pitfalls: everyone needs iron. Curr Sports Med Rep. 2012;11:50-1.
8. Fallon KE. Screening for haematological and iron-related abnormalities in elite athletes-analysis of 576 cases. J Sci Med Sport. 2008;11:329-36.
9. Favrat B, Balck K, Gasche C, et al. A single 1,000 mg iron dose of ferric carboxymaltose improves fatigue in iron deficient, nonanaemic premenopausal women-results of the randomised, placebo-controlled PREFER study. In: Proceedings of the XX FIGO World Congress of Gynecology and Obstetrics. Rome, Italy: 2012.
10. Finch CA, Miller LR, Inamdar AR, Person R, Seiler K, Mackler B. Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J Clin Invest. 1976;58:447-53.
11. Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol. 2001;98:806-14.
12. Friedmann B, Weller E, Mairbaurl H, Bartsch P. Effects of iron repletion on blood volume and performance capacity in young athletes. Med Sci Sports Exerc. 2001;33(5):741-6.
13. Ganzoni AM. [Intravenous iron-dextran: therapeutic and experimental possibilities]. Schweiz Med Wochenschr. 1970;100:301-3.
14. Garvican L, Martin D, Quod M, Stephens B, Sassi A, Gore C. Time course of the hemoglobin mass response to natural altitude training in elite endurance cyclists. Scand J Med Sci Sports. 2012;22:95-103.
15. Garvican LA, Burge CM, Cox AJ, Clark SA, Martin DT, Gore CJ. Carbon monoxide uptake kinetics of arterial, venous and capillary blood during CO rebreathing. Exp Physiol. 2011;95:1156-66.
16. Garvican LA, Eastwood A, Martin DT, Ross ML, Gripper A, Gore CJ. Stability of hemoglobin mass during a 6-day UCI ProTour cycling race. Clin J Sport Med. 2010;20:200-4.
17. Garvican LA, Lobigs L, Telford R, Fallon K, Gore CJ. Haemoglobin mass in an anaemic female endurance runner before and after iron supplementation. Int J Sports Physiol Perform. 2011;6:137-40.
18. Garvican LA, Martin DT, McDonald W, Gore CJ. Seasonal variation of haemoglobin mass in internationally competitive female road cyclists. Eur J Appl Physiol. 2010;109:221-31.
19. Garvican LA, Pottgiesser T, Martin DT, Schumacher YO, Barras M, Gore CJ. The contribution of haemoglobin mass to increases in cycling performance induced by simulated LHTL. Eur J Appl Physiol. 2011;111:1089-101.
20. Heinrich HC. Intestinal iron absorption in man: methods of measurements, dose relationship, diagnostic and therapeutic applications. In: Iron deficiency. Hallberg L, Harwerth HG, Vannotti A, editors. London: Academic Press; 1970. pp. 213-94.
21. Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc. 2009;41(1):3-13.
22. Janse de Jonge XA. Effects of the menstrual cycle on exercise performance. Sports Med. 2003;33:833-51.
23. Kim I, Yetley EA, Calvo MS. Variations in iron-status measures during the menstrual cycle. Am J Clin Nutr. 1993;58:705-9.
24. Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011;118:3222-7.
25. LaManca JJ, Haymes EM. Effects of iron repletion on VO2max, endurance, and blood lactate in women. Med Sci Sports Exerc. 1993;25(12):1386-92.
26. Latunde-Dada GO. Iron metabolism in athletes-achieving a gold standard. Eur J Haematol. 2012;90:10-5.
27. Lyle RM, Weaver CM, Sedlock DA, Rajaram S, Martin B, Melby CL. Iron status in exercising women: the effect of oral iron therapy vs increased consumption of muscle foods. Am J Clin Nutr. 1992;56:1049-55.
28. Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs. 2009;69:739-56.
29. Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl. 1999;69:S61-6.
30. Macdougall IC. Evolution of iv iron compounds over the last century. J Ren Care. 2009;35(Suppl 2):8-13.
31. Magazanik A, Weinstein Y, Abarbanel J, et al. Effect of an iron supplement on body iron status and aerobic capacity of young training women. Eur J Appl Physiol Occup Physiol. 1991;62: 317-23.
32. McClung JP. Iron status and the female athlete. J Trace Elem Med Biol. 2012;26:124-6.
33. McLane JA, Fell RD, McKay RH, Winder WW, Brown EB, Holloszy JO. Physiological and biochemical effects of iron deficiency on rat skeletal muscle. Am J Physiol. 1981;241:C47-C54.
34. Munoz M,Martin-Montanez E. Ferric carboxymaltose for the treatment of iron-deficiency anemia. [corrected]. Expert Opin Pharmacother. 2012;13:907-21.
35. Nachtigall D, Nielsen P, Fischer R, Engelhardt R, Gabbe EE. Iron deficiency in distance runners. A reinvestigation using Fe-labelling and non-invasive liver iron quantification. Int J Sports Med. 1996;17:473-9.
36. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-3.
37. Nielsen P, Nachtigall D. Iron supplementation in athletes. Current recommendations. Sports Med. 1998;26:207-16.
38. Prommer N, Schmidt W. Loss of CO from the intravascular bed and its impact on the optimised CO-rebreathing method. Eur J Appl Physiol. 2007;100:383-91.
39. Prommer N, Sottas PE, Schoch C, Schumacher YO, Schmidt W. Total hemoglobin mass-a new parameter to detect blood doping? Med Sci Sports Exerc. 2008;40(12):2112-8.
40. Robertson EY, Saunders PU, Pyne DB, Aughey RJ, Anson JM, Gore CJ. Reproducibility of performance changes to simulated live high/train low altitude. Med Sci Sports Exerc. 2010;42(2): 394-401.
41. Rodenberg RE, Gustafson S. Iron as an ergogenic aid: ironclad evidence? Curr Sports Med Rep. 2007;6:258-64.
42. Rowland TW, Deisroth MB, Green GM, Kelleher JF. The effect of iron therapy on the exercise capacity of nonanemic iron-deficient adolescent runners. Am J Dis Child. 1988;142:165-9.
43. Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. Scientific World Journal. 2012;2012:846-824.
44. Schmidt W, Prommer N. The optimised CO-rebreathing method: a new tool to determine total haemoglobin mass routinely. Eur J Appl Physiol. 2005;95:486-95.
45. Schmidt W, Prommer N. Impact of alterations in total hemoglobin mass on VO2max. Exerc Sport Sci Rev. 2010;38:68-75.
46. Schumacher YO, Pottgiesser T, Ahlgrim C, Ruthardt S, Dickhuth HH, Roecker K. Haemoglobin mass in cyclists during stage racing. Int J Sports Med. 2008;29:372-8.
47. Suominen P, Punnonen K, Rajamaki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood. 1998; 92:2934-9.
48. Vaiksaar S, Jurimae J, Maestu J, et al. No effect of menstrual cycle phase and oral contraceptive use on endurance performance in rowers. J Strength Cond Res. 2011;25:1571-8.
49. Van Wyck DB,Mangione A,Morrison J, Hadley PE, Jehle JA, Goodnough LT. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion. 2009;49: 2719-28.
50. von Drygalski A, Adamson JW. Ironing out fatigue. Blood. 2011; 118:3191-2.